Clinical Trials in Tennessee

Showing 4681-4700 of 20,239 trials

A Study of ADRX-0706 in Select Advanced Solid Tumors

NCT06036121

The primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0706 in patients with select advanced solid tumors.

Solid TumorsTriple Negative Breast Cancer (TNBC)Urothelial Cancer+1 more

Adcentrx Therapeutics144 participantsStarted Sep 2023

Los Angeles, California, United States • Los Angeles, California, United States • St. Petersburg, Florida, United States +18 more locations

COMPLETEDPhase 129 miles

Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer

NCT04666129

This study is being conducted to assess the safety and tolerability of relugolix with other agents approved for use in combination with androgen deprivation therapy (ADT) for a 12-week treatment period and an additional 40-week safety extension period in men with prostate cancer, either metastatic castration-sensitive prostate cancer (mCSPC) or non-metastatic or metastatic castration-resistant prostate cancer (nmCRPC or mCRPC).

Metastatic Castration-Resistant Prostate CancerMetastatic Castration-Sensitive Prostate CancerNon-Metastatic Castration-Resistant Prostate Cancer

Sumitomo Pharma America, Inc.48 participantsStarted Feb 2021

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Lakewood, Colorado, United States +13 more locations

A Study of ADRX-0706 in Select Advanced Solid Tumors

Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer

Find Trials by Condition in Tennessee

Main Study: A Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area Sub-study: A Follow-up Study to Evaluate the Analysis of Mammograms Following Treatment for Correction of Wrinkles in Décolletage Area in the Investigational Study 43USRV1906

A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

A Study of MK-8189 in Participants With Bipolar I Disorder (MK-8189-020)

VIZ ACCESS HCM - Multi-Site Registry

Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease

Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation

Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma

Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer

Active-control Randomized Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Cardiac Surgery

A Community-based Assessment of Skin Care, Allergies, and Eczema

Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis